Compare Prasidha Aneka Niaga Tbk (PSDN) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prasidha Aneka Niaga Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Prasidha Aneka Niaga Tbk trades at Rp141 (market cap 204.48B, 2.31M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Prasidha Aneka Niaga Tbk is the larger of the two by market cap. Which is the better fit depends on your goals.
| PSDN | SCPI | |
|---|---|---|
Market Cap | 204.48B | 104.4B |
Volume | 2.31M | — |
Lot | 23.05K | — |
Turnover | 321.59M | — |
Average Price | 139.49 | — |
Value | 321.59M | — |
Indicative Equilibrium Price | 141 | — |
Indicative Equilibrium Volume | 1.55K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prasidha Aneka Niaga Tbk
PT Prasidha Aneka Niaga Tbk was established based on Notarial deed No. 7 dated April 16, 1974 of Paul Tamara, under the name CV. Pagoda Palembang, Prasidha Aneka Niaga is a natural resources and industrial management company. In 1993 it acquired 7 businesses in its concentration , and entered hotel business.
Read more on PSDN →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
